Pacheco P, Marques N, Rodrigues P, Mansinho K, et al. Safety and Efficacy of Triple Therapy with Dolutegravir plus Two NRTIs, in Treatment-Naive HIV-2 Patients - Results from a 48-week Phase II Study. Clin Infect Dis 2023 Jun 8:ciad339. doi: 10.1093.
PMID: 37288954